Olaplex Holdings Surges 6.02% as Investor Sentiment Shifts Ahead of Market Open

Olaplex Holdings surged 6.015% in pre-market trading on December 26, 2025, signaling a potential shift in investor sentiment ahead of broader market open.

Analysts trimmed the stock’s price target to $1.40 while maintaining an Equal Weight rating, reflecting a nuanced adjustment to risk perception without altering long-term growth assumptions. The revised target underscores cautious optimism about execution and cost management but highlights near-term uncertainties that may cap upside potential.

Key valuation metrics remain largely stable, with a fair value estimate unchanged at $1.89 per share. Subtle declines in the discount rate and forward P/E multiple suggest a marginal easing of risk concerns, though analysts caution that structural challenges—including retail margin pressures and execution risks—remain embedded in the stock’s valuation.

Investors are now weighing whether strategic moves in scalp health innovation and international expansion can offset retail headwinds, with the stock’s trajectory likely to hinge on near-term operational clarity and product momentum.